Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel treatment options for anemia disclosed in recent GSK patents

April 27, 2007

Replacement of regular insulin with Oral-lyn studied in adults, adolescents

April 26, 2007

Recent Merck and AstraZeneca patents report new therapeutic agents for metabolic disorders

April 26, 2007

Approvable letter for bazedoxifene in prevention of postmenopausal osteoporosis

April 25, 2007

Japanese submission for Glufast in combination with insulin sensitizer

April 25, 2007

Improvements seen in type 2 diabetes patients given liraglutide

April 25, 2007

Phase III studies show efficacy and safety of ferumoxytol iron replacement therapy

April 25, 2007

Switch from epoetin alfa to Hematide feasible in dialysis patients

April 24, 2007

Clinical trial analyses reveal efficacy and safety of CERA in patients with renal anemia

April 24, 2007

DeveloGen and Andromeda Biotech sign term sheet for DiaPep277 purchase

April 24, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...